Source of material
Reagents and solvents used were of commercially available quality. Adamantaneamine was not aprimary reactant in this investigation. It was produced from decomposition of the N-2-hydroxy-3-methoxy-benzaldehyde-1-aminoadamanantane. The latter was synthesized according to [1] . NaHCO 3 (2 mmol) and N-2-hydroxy-3-methoxybenzaldehyde-1-aminoadamanantane (2 mmol) were dissolved in methanol (30 ml) solution and the mixture was stirred for 8hatroom temperature. The yellow solution was kept aside, and the yellow crystal was obtained after several days.
Experimental details
The crystal structure was solved by direct methods and successive Fourier difference syntheses. The Hatoms bonded to Cand Natoms were positioned geometrically and refined using ar iding
The Hatoms bonded to Oatoms were located in ad ifference Fourier maps and refined with O-H distance restraints of 0.85(2) Å and Uiso(H) =1.5 U eq (O).
Discussion
Adamantane has ah ighly-symmetric and steady structure. Adamantaneamine has an obvious effect on controlling the exuviating the influenza Avirus. Especially, it can be used to prevent virus going into host cells and influenza A 2 in asia. In addition it can alleviate the Parkinson symptom [2] . The title crystal structure is formed by adamantaneamine cations and bicarbonate anions. All the C-C bonds (C1-C10) are in the range of 1.516(3) Å -1.535(3) Å in the adamantyl group, with C-C-Cb ond angles of 108.7(2)°-110.3(2)°, which is consistent with diamond-like unit. The C-N bond length is 1.503(3) Å.The bicarbonate anion and the adamantaneamine cation are connected with each other with hydrogen bonds. These hydrogen bonds contribute to the formation of atwo-dimensional network. 
